NOTICE OF INTENT TO SOLE SOURCE - ILLUMINA REAGENTS
ID: 75D30124Q78095Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/32c72a0d0490435ca7c15f75ffe67ef6/view
Timeline
    Description

    The U.S. Centers for Disease Control and Prevention (CDC) intends to award a sole-source contract to Illumina, Inc., a crucial supplier of test kits for DNA sequencing and library preparation. The procurement aims to ensure continuity in influenza research and public health laboratories, as these kits are compatible only with Illumina's sequencing instruments. The CDC requires these specialized kits for essential tasks in analyzing and comparing influenza data, which plays a significant role in determining the annual influenza vaccine composition. Interested parties should contact Jennifer Gartzke for more information.

    Point(s) of Contact
    Jennifer Gartzke
    (404) 498-0020
    xuy7@cdc.gov
    Files
    Title
    Posted
    A1B_Statement of Requirements1.docx
    Lifecycle
    Title
    Type
    NOTICE OF INTENT TO SOLE SOURCE - ILLUMINA REAGENTS
    Currently viewing
    Presolicitation
    NOTICE OF INTENT TO SOLE SOURCE - ILLUMINA REAGENTS
    Special Notice
    Similar Opportunities
    CDC Small Business Engagement Summit
    Active
    Health And Human Services, Department Of
    Presolicitation HEALTH AND HUMAN SERVICES, DEPARTMENT OF intends to award a sole source contract to QIAGEN, LLC for the procurement of an EZ! Advanced XL System. This system is typically used for In-Vitro Diagnostic Substance Manufacturing. The contract is for supplies or services under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). Interested parties may submit proposals within five days of the issuance of this notice. The deadline for submission is 06:00AM, July 24, 2023.
    DNA SEQUENCING SYSTEM MAINTENANCE SUPPORT AGREEMENTS
    Active
    Commerce, Department Of
    The Department of Commerce, specifically the National Institute of Standards and Technology (NIST), intends to negotiate a sole source contract for maintenance support agreements related to the Illumina MiSeq FGx DNA Sequencing System and its associated Data Analysis Server. The procurement aims to renew a Full Service Agreement and a Standard Service Agreement with Qiagen LLC, the only authorized service provider with certified engineers and OEM parts for this equipment. This maintenance support is crucial for ensuring the operational integrity and reliability of the DNA sequencing system, which plays a significant role in various scientific and research applications. Interested parties may express their interest and capability by contacting Randy E. Schroyer via email by 5:00 PM EST on September 10, 2024, as no formal solicitation package will be issued.
    MagPlex C Microsphere Beads
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking quotations for the supply of MagPlex C Microsphere Beads, which are critical for serological assays used to quantify antibodies for various disease targets in public health surveillance. These microspheres are uniquely compatible with the CDC's existing assays based on Luminex’s Xmap technology, and no alternative products have been identified that can replace them without compromising the integrity of past study comparisons. Interested vendors must submit their quotations by 5:00 PM EST on September 10, 2024, with delivery expected by December 31, 2024; inquiries should be directed to Gary Morgan at glm5@cdc.gov or by phone at 770-488-2639.
    Sequencing reagents and flow cells
    Active
    National Aeronautics And Space Administration
    NASA's National Aeronautics and Space Administration (NASA) is seeking to procure sequencing reagents and flow cells, which are critical for RNA sequencing from various tissues collected during space missions. This procurement is part of the NASA GeneLab project, aimed at expanding the volume and utility of omics data from spaceflight experiments, and the reagents must be compatible with the Illumina NovaSeq 6000 platform to ensure effective library preparation and sequencing. The selected contractor will deliver the required reagents to the NASA Ames Research Center within 15 days post-contract award, with options for partial deliveries, emphasizing NASA's commitment to advancing biological research. Interested organizations must submit their capabilities and qualifications in writing to Sara Jusino-Terry at sara.a.jusino-terry@nasa.gov by 12 p.m. Central Standard Time on September 9, 2024, to be considered for this sole source contract with Illumina, Inc.
    Notice of Intent to Sole Source W.E.L. Instruments
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price purchase order to W.E.L. Instruments Company for the acquisition of a Carl Zeiss Axiovert 5 inverted digital all-in-one cell imaging microscope. This specialized instrument is essential for performing specific functions that meet the CDC's requirements, and W.E.L. Instruments Company is the only known supplier capable of providing this equipment. Interested parties may express their interest and capability to respond to this requirement, although this notice is not a request for competitive quotations. Quotations or responses should be submitted via email to Christopher Ragucci at zdm3@cdc.gov by the specified deadline for consideration.
    Genomics Sequencing Services for the NIAID Centralized Sequencing Program
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotes for genomics sequencing services to support its Centralized Sequencing Program (CSP). The procurement aims to provide comprehensive whole genome sequencing, including variant interpretation and clinical reports, to enhance clinical research on infectious diseases, with results expected within four weeks of sample receipt. This initiative is critical for advancing the understanding of genetic factors in disease and improving patient care through genomic evaluations. Interested vendors must submit their quotes by 3:00 PM EST on September 13, 2024, to the primary contact, Seth Schaffer, at seth.schaffer@nih.gov, with the solicitation number RFQ-NIAID-24-2224314.
    Platinum TAQ DNA Polymerase kit, 5000 reactions per kit
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS) intends to award a Firm-Fixed Price Contract to Life Technologies Inc. for the provision of the Platinum TAQ DNA Polymerase kit, which supports 5000 reactions per kit. This procurement is specifically aimed at supporting the BioWatch Laboratory Operations, highlighting the critical role of this reagent in public health and safety initiatives. Interested vendors are invited to express their capabilities by emailing Leslie Lucas at leslie.lucas@hhs.gov by 10:00 am EST on September 18, 2024, although the government reserves the right to proceed without competition under the authority of specific federal regulations.
    Quantification Polymerase Chain Reaction Analytical Instrument
    Active
    Commerce, Department Of
    The National Oceanic and Atmospheric Administration (NOAA) intends to negotiate a sole-source procurement with Remel, Inc., a division of Thermo Fisher Scientific, LLC, for the acquisition of a Quant Studio 5 and a SimpliAmp Thermal Cycler, which are critical for ruminant DNA testing at the National Seafood Inspection Laboratory in Pascagoula, Mississippi. The procurement is necessitated by NOAA's specific requirement for these instruments, as Remel is the sole manufacturer and distributor of the requested equipment. This advanced analytical instrumentation will support projects aimed at quantifying DNA sequences, thereby enhancing natural resource management through improved data on key species and their environmental contexts. Interested parties may submit documentation to the primary contact, Raynier Camerino, at raynier.camerino@noaa.gov within 15 days of this notice, with delivery expected within 30 days from the award date.
    Intent to Sole Source - DNA Purification System
    Active
    Agriculture, Department Of
    The Department of Agriculture's Forest Service, specifically the Pacific Northwest Research Station, intends to award a sole-source contract for the acquisition of a Thermo Scientific™ KingFisher™ Duo Prime Purification System. This specialized equipment is essential for projects focused on detecting invasive forest pathogens, which require high-quality DNA extraction from complex samples such as soil and water. The KingFisher system, utilizing advanced magnetic bead technology, allows for efficient processing of up to 96 samples simultaneously, addressing previous challenges faced with conventional DNA extractors. For further inquiries, interested parties can contact Nola Wisenor at nola.wisenor@usda.gov.
    RISER Sources Sought
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking potential vendors for its Resources for Improvement of Surveillance and Emergency Response (RISER) program through a sources sought notice. The primary objective of this procurement is to enhance the availability and quality of laboratory reagents necessary for public health surveillance and emergency response, including the production of high-quality reference pathogens and the management of reagent distribution. This initiative is critical for supporting CDC's ongoing surveillance activities, vaccine development, and research related to public health issues. Interested parties are encouraged to submit their capabilities by September 17, 2024, and can contact Jennifer Gartzke at xuy7@cdc.gov or 404-498-0020 for further information.